Modernized trading structure enables faster trading and broader market access

New York, NY – TheNewswire - April 8, 2026 – Synbio International Inc. (OTC: SYIN) today announced that the Company has been approved for Deposit/Withdrawal at Custodian (DWAC) and Direct Registration System (DRS) processing through its transfer agent, Pacific Stock Transfer Company.

This milestone represents an important step in Synbio’s ongoing efforts to modernize its trading infrastructure and improve accessibility for both existing shareholders and prospective investors.

DWAC eligibility enables electronic transfer of shares between broker-dealers and the Company’s transfer agent, eliminating the need for physical share certificates, reducing settlement times, and lowering transaction friction for more efficient trading in the open market.

In parallel, DRS allows shareholders to hold their shares directly on the books of the Company in electronic form, without requiring a physical certificate or intermediary custody. This provides investors with greater control, enhanced ownership security, and simplified transferability.

“Achieving DWAC and DRS eligibility is a foundational step in strengthening Synbio’s capital markets platform,” said Claudio Solitario, CEO of Synbio International.  “As we continue to advance our strategic initiatives, including our planned financing activities and partnership developments, it is critical that our stock is easily accessible and efficiently tradable for the investment community. This positions the Company to move quickly as we execute on a number of near-term initiatives currently in progress.”

This development comes as Synbio continues to transition toward a more investor-ready, execution-focused public company platform, with multiple near-term capital markets and operational catalysts expected.

About Synbio International Inc.

Synbio International Inc. (OTC: SYIN) is a medical research and technology company focused on clinically validated AI-driven medical diagnostics. Through strategic partnerships and research collaborations, Synbio aims to bridge the gap between wellness and medicine, developing science-based solutions that improve quality of life and empower healthcare providers.

For media inquiries, please contact:
Synbio International Inc.
info@synbiointl.com
(646) 359-4854
www.synbiointl.com

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements in this press include, among others, statements about our renegotiated settlement agreement. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans, and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our limited operating history; our dependence on third parties for many aspects of our business; general market and economic conditions; technical factors; the availability of outside capital; our receipt of revenues; legislative developments; changes in our expenditures and other uses of cash; our ability to find, recruit and retain personnel in sufficient numbers to support our growth; our ability to manage growth; and general market, economic and business conditions. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.